logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Obesity

    FiltersReset Filters
    11 results

    • amphetamine sulfate

      (Amphetamine Sulfate)
      Granules Pharmaceuticals Inc.
      Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity in conjunction with a comprehensive treatment program, and as a short-term adjunct for exogenous obesity in patients not responding to other weight loss strategies.

    • amphetamine sulfate

      (amphetamine sulfate)
      Lannett Company, Inc.
      Usage: Amphetamine sulfate tablets (5 mg and 10 mg) are indicated for narcolepsy, Attention Deficit-Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term management of exogenous obesity as an adjunct to a caloric restriction regimen in patients unresponsive to other therapies.

    • contrave

      (naltrexone hydrochloride and bupropion hydrochloride)
      Nalpropion Pharmaceuticals LLC
      Usage: CONTRAVE is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater (obese) or 27 kg/m² or greater (overweight) with weight-related comorbid conditions, as an adjunct to diet and exercise. Safety with other weight loss products is not established.

    • diethylpropion hydrochloride

      (Diethylpropion Hydrochloride)
      Lannett Company, Inc.
      Usage: Diethylpropion hydrochloride extended-release tablets, 75 mg, are indicated for short-term management of exogenous obesity in patients with a BMI of 30 kg/m² or higher who have not responded to diet and exercise alone. It is intended for use as monotherapy.

    • lomaira

      (Phentermine Hydrochloride)
      KVK-Tech Inc
      Usage: LOMAIRA™ tablets are indicated for short-term weight reduction as an adjunct to exercise, behavioral modification, and caloric restriction in patients with a body mass index (BMI) of ≥30 kg/m², or ≥27 kg/m² with risk factors like controlled hypertension, diabetes, or hyperlipidemia.

    • phentermine hydrochloride

      (phentermine hydrochloride)
      SUNRISE PHARMACEUTICAL, INC.
      Usage: Phentermine hydrochloride capsules are indicated as a short-term adjunct to weight reduction programs, including exercise, behavioral modification, and caloric restriction, for patients with exogenous obesity (BMI ≥ 30 kg/m² or ≥ 27 kg/m² with risk factors like hypertension, diabetes, or hyperlipidemia).

    • phentermine hydrochloride

      (Phentermine Hydrochloride)
      TAGI Pharma, Inc
      Usage: Phentermine hydrochloride capsules are indicated for short-term use (a few weeks) in conjunction with exercise, behavioral modification, and caloric restriction for weight reduction in adults with a body mass index ≥30 kg/m² or ≥27 kg/m² with risk factors like hypertension or diabetes.

    • saxenda

      (liraglutide)
      Novo Nordisk
      Usage: SAXENDA is indicated for weight management in adults and patients aged 12 and older with obesity (≥60 kg) or with overweight plus a weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity. Coadministration with other liraglutide-containing products is not recommended.

    • wegovy

      (semaglutide)
      Novo Nordisk
      Usage: WEGOVY is indicated, alongside a reduced-calorie diet and increased physical activity, for reducing the risk of major cardiovascular events in adults with cardiovascular disease and obesity or overweight, and for long-term weight reduction in adolescents aged 12 and older with obesity and adults with overweight and related comorbidities.

    • xenical

      (orlistat)
      H2-Pharma LLC
      Usage: XENICAL is indicated for managing obesity through weight loss and maintenance, alongside a reduced-calorie diet. It also helps prevent weight regain post-weight loss and is suitable for obese patients with a BMI ≥30 kg/m² or ≥27 kg/m² with additional risk factors like hypertension, diabetes, or dyslipidemia.